Fierce Biotech January 5, 2024
Conor Hale

The maker of a wearable garment for tracking heart rate, breathing and physical activity has obtained an FDA clearance for artificial intelligence-powered software that enables continuous monitoring of blood pressure without an inflatable cuff.

Fit snugly across a person’s chest, Nanowear’s SimpleSense wearable is built with cloth-based sensor technology to provide medical-grade remote vital sign tracking, including ECG data and heart sounds.

The new 510(k) green light—marking the company’s fourth—for the SimpleSense-BP program aims to support the at-home diagnosis of hypertension, as well as within healthcare facilities or clinical studies. Everyday settings can lead to more accurate readings than under the examination of a physician, where anxiety may raise blood pressure levels while calm, controlled breathing may lower them.

“This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article